Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia

Br J Haematol. 2002 Dec;119(4):985-7. doi: 10.1046/j.1365-2141.2002.03964.x.

Abstract

Genetic polymorphisms in the tumour necrosis factor (TNF) locus influence the outcome of non-Hodgkin's lymphoma (NHL). We investigated whether these polymorphisms might contribute to the clinical course of childhood acute lymphoblastic leukaemia (ALL). Genomic DNA from 214 childhood ALL patients was analysed. Patients with a high-risk haplotype were older than patients with low-risk haplotype (P = 0.024). No statistically significant associations were found between TNF haplotype and sex, WBC counts, central nervous system involvement, immunophenotype, response to chemotherapy, and event-free survival. These data suggest that genetic polymorphisms in the TNF locus have a limited effect on the outcome of childhood ALL.

Publication types

  • Multicenter Study

MeSH terms

  • Age Factors
  • Child
  • Disease-Free Survival
  • Female
  • Haplotypes
  • Humans
  • Lymphotoxin-alpha / genetics
  • Male
  • Polymorphism, Genetic*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Prognosis
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Lymphotoxin-alpha
  • Tumor Necrosis Factor-alpha